Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc(CELZ)資訊與事件

$1.140

0.000 (0.00%)收盤時

CELZ 資訊

CELZ 事件

8/20 10:00

Creative Medical Completes Patient Enrollment for CELZ-201 Clinical Trial

Creative Medical announced that all patients have now been enrolled and treated across the company's entire FDA-cleared ADAPT clinical trial evaluating CELZ-201 / Olastrocel, including the original study cohorts and the FDA-cleared opioid expansion cohort.

7/24 16:30

Creative Medical Files to Sell 5.58M Shares of Common Stock

Creative Medical files to sell 5.58M shares of common stock for holders

6/30 14:30

Creative Medical Technology Enters Agreement for Immediate Exercise of 2,790,340 Warrants

Creative Medical Technology announced that it has entered into agreements with certain holders of its existing warrants for the immediate exercise of outstanding warrants to purchase up to an aggregate of 2,790,340 shares of common stock of the Company originally issued in October 2025, at a reduced exercise price of $1.60 per share. The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to an effective registration statement on Form S-3. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $4.5M, before deducting financial advisory fees. Roth Capital Partners is acting as the company's financial advisor for this transaction. In consideration for the immediate exercise of the existing warrants for cash, the company will issue new unregistered warrants to purchase shares of common stock. The new warrants will be exercisable for an aggregate of up to 5,580,680 shares of common stock, at an exercise price of $1.60 per share upon the receipt of shareholder approval for a term of five years from the initial exercise date. The transaction is expected to close on June 30, 2026. The company intends to use the net proceeds from the offering for working capital and general corporate purposes.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始